AVTX (Avalo Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Avalo Therapeutics, Inc. Common Stock (AVTX) is a publicly traded Healthcare sector company. As of May 21, 2026, AVTX trades at $16.84 with a market cap of $849.46M and a P/E ratio of -2.79. AVTX moved +0.15% today. Year to date, AVTX is +1.62%; over the trailing twelve months it is +297.32%. Its 52-week range spans $3.39 to $24.27. Analyst consensus is strong buy with an average price target of $46.78. Rallies surfaces AVTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AVTX stock?

Hedge funds tracked by Rallies that own AVTX include Farallon Capital and Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Avalo Therapeutics, Inc. Common Stock.

AVTX Key Metrics

Key financial metrics for AVTX
MetricValue
Price$16.84
Market Cap$849.46M
P/E Ratio-2.79
EPS$-5.84
Dividend Yield0.00%
52-Week High$24.27
52-Week Low$3.39
Volume321
Avg Volume0
Revenue (TTM)$59.00K
Net Income$-78.26M
Gross Margin0.00%

Top Hedge Funds Holding AVTX

  • Farallon Capital holds 916.00K shares of AVTX, changed +0.00% as of Mar 31, 2026.
  • Orbimed Advisors holds 475.17K shares of AVTX, changed -59.98% as of Mar 31, 2026.

Latest AVTX News

Recent AVTX Insider Trades

  • Sullivan Christopher Ryan sold 18.61K (~$448.82K) on May 7, 2026.
  • VARKI PAUL sold 37.38K (~$706.84K) on May 6, 2026.
  • VARKI PAUL sold 5.20K (~$102.78K) on May 6, 2026.

AVTX Analyst Consensus

9 analysts cover AVTX: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $46.78.

Common questions about AVTX

Who owns AVTX stock?
Hedge funds tracked by Rallies that own AVTX include Farallon Capital and Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Avalo Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for AVTX?
Yes. Rallies tracks hedge fund and 13F ownership data for AVTX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AVTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AVTX. It does not provide personalized investment advice.
AVTX

AVTX